Interaction between Haemochromatosis and Transferrin Receptor Genes in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|59|4|317-322

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.4, 2000-11, pp. : 317-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 278-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma

By  

Current Drug Safety, Vol. 8, Iss. 2, 2013-04 ,pp. : 148-152

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 481-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 372-380

Karger

Access to resources Recommend Favorite

The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 361-368

Karger

Access to resources Recommend Favorite